You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

Claims for Patent: 5,945,449


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,945,449
Title: Sterile bicarbonate concentrate
Abstract:A sterile bicarbonate concentrate for use in the present invention relates to a sterile calcium-free bicarbonate concentrate for use in peritoneal dialysis, hemofiltration, cardiac bypass surgery and in electrolyte replacement therapy.
Inventor(s): Purcell; Larry Joseph (Toronto, CA), Tobe; Sheldon William (North York, CA)
Assignee: Dialysis Solutions Inc. (Toronto, CA)
Application Number:08/961,778
Patent Claims: 1. A method for providing continuous renal replacement therapy to a patient comprising administering a calcium-free sterile dialysis solution comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 106.5.+-.10 mmol/l, and HCO3 35.0.+-.3.5 mmol/l to a patient in need thereof.

2. A method for providing peritoneal dialysis to a patient comprising administering a calcium-free sterile dialysis solution comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 106.5.+-.10 mmol/l, and HCO3 35.0.+-.3.5 mmol/l to a patient in need thereof.

3. A method according to claim 2 wherein the dialysis solution further comprises dextrose in a concentration of 2.5% w/v.

4. A method of reducing potassium levels and fluid volume during cardiopulmonary bypass surgery comprising administering a calcium-free sterile dialysis solution comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 106.5.+-.10 mmol/l, and HCO3 35.0.+-.3.5 mmol/l to a patient in need thereof.

5. A method for hemofiltration comprising administering a calcium-free sterile infusate comprising Na 140.+-.14 mmol/l Mg 0.75.+-.0.07 mmol/l, Cl 106.5.+-.10 mmol/l, and HCO3 35.0.+-.3.5 mmol/l to a patient in need thereof.

6. A method of treating dysentery comprising administering a calcium-free sterile solution comprising 90 mMol/l sodium; 68.5 mMol/l chloride; 22 mMol/l bicarbonate; and 277 mMol/l glucose to a person in need thereof.

7. A kit for preparing a dialysis solution comprising (a) one 80 ml unit of a calcium-free concentrate comprising sodium chloride (NaCl) 86.87.+-.8.6 g/l, magnesium chloride (MgCl.sub.2) 2.05.+-.0.2 g/l, and sodium bicarbonate NaHCO.sub.3) 39.69.+-.3.9 g/l and (b) one litre of sterile water.

8. A kit for preparing a dialysis solution according to claim 7 further comprising (c) one litre of a 5% w/v dextrose solution in water and (d) a second 80 ml unit of a concentrate comprising sodium chloride (NaCl) 86.87.+-.8.6 g/l, magnesium chloride (MgCl.sub.2) 2.05.+-.0.2 g/l, and sodium bicarbonate NaHCO.sub.3) 39.69.+-.3.9 g/l.

9. A method of preparing a sterile dialysis solution comprising diluting a sterile, calcium free bicarbonate dialysis concentrate comprising sodium chloride (NaCl) 86.87.+-.8.6 g/l, magnesium chloride (MgCl.sub.2) 2.05.+-.0.2 g/l, and sodium bicarbonate (NaHCO.sub.3) 39.69.+-.3.9 g/l in a sufficient amount of water to prepare a dialysis solution comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 106.5.+-.10 mmol/l, and HCO3 35.0.+-.3.5 mmol/l.

10. A method for providing continuous renal replacement therapy to a patient in need thereof comprising administering a sterile dialysis solution prepared according to the method of claim 9 to a patient in need thereof.

11. A method for providing peritoneal dialysis to a patient comprising administering a sterile dialysis solution prepared according to the method of claim 9 to a patient in need thereof.

12. A method of reducing potassium levels and fluid volume during cardiopulmonary bypass surgery comprising administering a sterile dialysis solution prepared according to the method of claim 9 to a patient in need thereof.

13. A method for treating acute renal failure in a critically ill patient without introducing calcium into the blood removed from the patient during dialysis comprising administering a sterile dialysis solution prepared according to the method of claim 9 to a patient in need thereof.

14. A method for treating acute renal failure in a critically ill patient without introducing calcium into the blood removed from the patient during dialysis comprising administering a calcium-free sterile dialysis solution comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 106.5.+-.10 mmol/l, and HCO3 35.0.+-.3.5 mmol/l to a patient in need thereof.

15. A method according to claim 10 wherein the patient is a liver transplantation patient.

16. A method of preparing a sterile infusate comprising diluting a sterile, calcium free bicarbonate concentrate comprising sodium chloride (NaCl) 86.87.+-.8.6 g/l, magnesium chloride (MgCl.sub.2) 2.05.+-.0.2 g/l, and sodium bicarbonate (NaHCO.sub.3) 39.69.+-.3.9 g/l in a sufficient amount of water to prepare an infusate comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 106.5.+-.10 mmol/l, and HCO3 35.0.+-.3.5 mmol/l.

17. A method for providing hemofiltration to a patient comprising administering a sterile infusate prepared according to the method of claim 16 to a patient in need thereof.

18. A method of preparing a sterile oral electrolyte solution for fluid replacement comprising diluting a sterile, calcium free bicarbonate concentrate comprising sodium chloride (NaCl) 86.87.+-.8.6 g/l, magnesium chloride (MgCl.sub.2) 2.05 .+-.0.2 g/l, and sodium bicarbonate (NaHCO.sub.3) 39.69.+-.3.9 g/l in a sufficient amount of water to prepare an electrolyte solution comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 106.5.+-.10 mmol/l, and HCO3 35.0.+-.3.5 mmol/l.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.